文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

危重患者全身性脓毒症诱导的急性呼吸衰竭表型的推导与验证:一项回顾性研究

Derivation and validation of generalized sepsis-induced acute respiratory failure phenotypes among critically ill patients: a retrospective study.
PubMed 文献 · Crit Care · 2024-10-01
一句话结论脓毒症合并急性呼吸衰竭需机械通气患者可稳定复现4种表型(A重度多器官功能障碍伴肾损伤/心衰高可能、B重度低氧血症、C轻度低氧、D重度多器官功能障碍伴肝损伤/凝血障碍/乳酸酸中毒),28天死亡率差异显著(p<0.01)。

该多中心回顾性研究在Hospital-I的MICU(N=3225)中,利用插管前24h临床数据,通过可解释的机器学习聚类模型并由临床专家解读,推导出4种脓毒症诱导的急性呼吸衰竭表型。表型在Hospital-II的MICU(N=848)及两家医院的SICU(N=1112、N=465)中均成功复现。Kaplan-Meier分析显示各表型28天死亡率差异显著(p<0.01),且在两家医院的MICU和SICU中一致。各表型在高呼气末正压(PEEP)策略的治疗效应上存在差异。

要点

  • 在脓毒症需机械通气≥24h的ICU患者中,推导并外部验证出4种急性呼吸衰竭表型:A(重度多器官功能障碍,肾损伤和心衰可能性高)、B(重度低氧血症,中位P/F=123)、C(轻度低氧,中位P/F=240)、D(重度多器官功能障碍,肝损伤、凝血障碍和乳酸酸中毒可能性高)。
  • 各表型28天死亡率差异显著(p<0.01),且在Hospital-I和Hospital-II的MICU与SICU中保持一致。
  • 各表型在高PEEP策略相关的治疗效应上存在差异。

适用人群与场景

  • ICU中脓毒症并需要机械通气≥24h的成人患者;推导队列来自Hospital-I的MICU(N=3225),验证队列来自Hospital-II的MICU(N=848)、Hospital-I的SICU(N=1112)及Hospital-II的SICU(N=465)。

诊断标准与关键阈值

  • 表型A:重度多器官功能障碍,肾损伤和心衰可能性高;表型B:重度低氧血症,中位P/F=123;表型C:轻度低氧,中位P/F=240;表型D:重度多器官功能障碍,肝损伤、凝血障碍和乳酸酸中毒可能性高。

研究设计与关键结果

  • 多中心回顾性研究,在Hospital-I的MICU(N=3225)中利用插管前24h临床数据,通过可解释的机器学习聚类模型并由临床专家解读推导出4种表型。
  • 表型在Hospital-II的MICU(N=848)、Hospital-I的SICU(N=1112)及Hospital-II的SICU(N=465)中均成功复现。
  • Kaplan-Meier分析显示各表型28天死亡率差异显著(p<0.01),且在两家医院的MICU和SICU中一致。
  • 各表型在高PEEP策略相关的治疗效应上存在差异。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些表型展示了独特的器官损伤模式和临床结局差异,可能有助于为未来的研究和临床试验设计提供信息,以制定量身定制的管理策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Septic patients who develop acute respiratory failure (ARF) requiring mechanical ventilation represent a heterogenous subgroup of critically ill patients with widely variable clinical characteristics. Identifying distinct phenotypes of these patients may reveal insights about the broader heterogeneity in the clinical course of sepsis, considering multi-organ dynamics. We aimed to derive novel phenotypes of sepsis-induced ARF using observational clinical data and investigate the generalizability of the derived phenotypes.

METHODS: We performed a multi-center retrospective study of ICU patients with sepsis who required mechanical ventilation for ≥ 24 h. Data from two different high-volume academic hospital centers were used, where all phenotypes were derived in MICU of Hospital-I (N = 3225). The derived phenotypes were validated in MICU of Hospital-II (N = 848), SICU of Hospital-I (N = 1112), and SICU of Hospital-II (N = 465). Clinical data from 24 h preceding intubation was used to derive distinct phenotypes using an explainable machine learning-based clustering model interpreted by clinical experts.

RESULTS: Four distinct ARF phenotypes were identified: A (severe multi-organ dysfunction (MOD) with a high likelihood of kidney injury and heart failure), B (severe hypoxemic respiratory failure [median P/F = 123]), C (mild hypoxia [median P/F = 240]), and D (severe MOD with a high likelihood of hepatic injury, coagulopathy, and lactic acidosis). Patients in each phenotype showed differences in clinical course and mortality rates despite similarities in demographics and admission co-morbidities. The phenotypes were reproduced in external validation utilizing the MICU of Hospital-II and SICUs from Hospital-I and -II. Kaplan-Meier analysis showed significant difference in 28-day mortality across the phenotypes (p < 0.01) and consistent across MICU and SICU of both Hospital-I and -II. The phenotypes demonstrated differences in treatment effects associated with high positive end-expiratory pressure (PEEP) strategy.

CONCLUSION: The phenotypes demonstrated unique patterns of organ injury and differences in clinical outcomes, which may help inform future research and clinical trial design for tailored management strategies.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Choudhary T, Upadhyaya P, Davis CM, et al. Derivation and validation of generalized sepsis-induced acute respiratory failure phenotypes among critically ill patients: a retrospective study. Crit Care. 2024. PMID: 39354616. doi:10.1186/s13054-024-05061-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。